192 related articles for article (PubMed ID: 35176268)
1. α-Synuclein in Parkinson's disease and advances in detection.
Chen R; Gu X; Wang X
Clin Chim Acta; 2022 Apr; 529():76-86. PubMed ID: 35176268
[TBL] [Abstract][Full Text] [Related]
2. Electrochemical biosensors for the detection and study of α-synuclein related to Parkinson's disease - A review.
Hassan Q; Li S; Ferrag C; Kerman K
Anal Chim Acta; 2019 Dec; 1089():32-39. PubMed ID: 31627816
[TBL] [Abstract][Full Text] [Related]
3. Alpha-Synuclein as a Biomarker for Parkinson's Disease.
Atik A; Stewart T; Zhang J
Brain Pathol; 2016 May; 26(3):410-8. PubMed ID: 26940058
[TBL] [Abstract][Full Text] [Related]
4. Efficient Entrapment of Alpha-Synuclein Biotinylated Antibody in KCC-1-NH-CS
Navay Baghban H; Hasanzadeh M; Liu Y; Seidi F
Biosensors (Basel); 2022 Oct; 12(10):. PubMed ID: 36291047
[TBL] [Abstract][Full Text] [Related]
5. Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics.
Yamasaki TR; Holmes BB; Furman JL; Dhavale DD; Su BW; Song ES; Cairns NJ; Kotzbauer PT; Diamond MI
J Biol Chem; 2019 Jan; 294(3):1045-1058. PubMed ID: 30478174
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Plasmonic Biosensor Utilizing Paired Antibody and Label-Free Fe
Mandala SHS; Liu TJ; Chen CM; Liu KK; Januar M; Chang YF; Lai CS; Chang KH; Liu KC
Biosensors (Basel); 2021 Oct; 11(10):. PubMed ID: 34677358
[TBL] [Abstract][Full Text] [Related]
7. Methods for detecting toxic α-synuclein species as a biomarker for Parkinson's disease.
O'Hara DM; Kalia SK; Kalia LV
Crit Rev Clin Lab Sci; 2020 Aug; 57(5):291-307. PubMed ID: 32116096
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylated α-synuclein in diluted human serum as a biomarker for Parkinson's disease.
Chen WR; Chen JC; Chang SY; Chao CT; Wu YR; Chen CM; Chou C
Biomed J; 2022 Dec; 45(6):914-922. PubMed ID: 34974168
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathies.
Herrmann Y; Bujnicki T; Zafiu C; Kulawik A; Kühbach K; Peters L; Fabig J; Willbold J; Bannach O; Willbold D
Clin Chim Acta; 2017 Mar; 466():152-159. PubMed ID: 28088342
[TBL] [Abstract][Full Text] [Related]
10. A review of the current research on in vivo and in vitro detection for alpha-synuclein: a biomarker of Parkinson's disease.
Wang R; Pang SC; Li JY; Li CL; Liu JM; Wang YM; Chen ML; Li YB
Anal Bioanal Chem; 2023 Apr; 415(9):1589-1605. PubMed ID: 36688984
[TBL] [Abstract][Full Text] [Related]
11. A novel, label-free liquid crystal biosensor for Parkinson's disease related alpha-synuclein.
Yang X; Li H; Zhao X; Liao W; Zhang CX; Yang Z
Chem Commun (Camb); 2020 May; 56(40):5441-5444. PubMed ID: 32292959
[TBL] [Abstract][Full Text] [Related]
12. Investigation of α-Synuclein Species in Plasma Exosomes and the Oligomeric and Phosphorylated α-Synuclein as Potential Peripheral Biomarker of Parkinson's Disease.
Zheng H; Xie Z; Zhang X; Mao J; Wang M; Wei S; Fu Y; Zheng H; He Y; Chen H; Xu Y
Neuroscience; 2021 Aug; 469():79-90. PubMed ID: 34186110
[TBL] [Abstract][Full Text] [Related]
13. Detection of skin α-synuclein using RT-QuIC as a diagnostic biomarker for Parkinson's disease in the Chinese population.
Li J; Duan S; Yang J; Zheng H; Yuan Y; Tang M; Wang Y; Liu Y; Xia Z; Luo H; Xu Y
Eur J Med Res; 2024 Feb; 29(1):114. PubMed ID: 38336827
[TBL] [Abstract][Full Text] [Related]
14. Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.
Visanji NP; Marras C; Hazrati LN; Liu LW; Lang AE
Mov Disord; 2014 Apr; 29(4):444-50. PubMed ID: 24375496
[TBL] [Abstract][Full Text] [Related]
15. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
[TBL] [Abstract][Full Text] [Related]
16. Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson's Disease.
Fricova D; Harsanyiova J; Kralova Trancikova A
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212934
[TBL] [Abstract][Full Text] [Related]
17. Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson's Disease.
Vivacqua G; Latorre A; Suppa A; Nardi M; Pietracupa S; Mancinelli R; Fabbrini G; Colosimo C; Gaudio E; Berardelli A
PLoS One; 2016; 11(3):e0151156. PubMed ID: 27011009
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal study on α-synuclein in plasma neuronal exosomes as a biomarker for Parkinson's disease development and progression.
Niu M; Li Y; Li G; Zhou L; Luo N; Yao M; Kang W; Liu J
Eur J Neurol; 2020 Jun; 27(6):967-974. PubMed ID: 32150777
[TBL] [Abstract][Full Text] [Related]
19. C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease.
Ma L; Yang C; Zhang X; Li Y; Wang S; Zheng L; Huang K
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3714-3725. PubMed ID: 30290273
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease biomarkers based on α-synuclein.
Fayyad M; Salim S; Majbour N; Erskine D; Stoops E; Mollenhauer B; El-Agnaf OMA
J Neurochem; 2019 Sep; 150(5):626-636. PubMed ID: 31265130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
